Clinical trial registry record

GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated September 8, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06813261
Last registry update
September 8, 2025
Status
Recruiting
Phase
Phase not reported
Sponsor
Buck Institute for Research on Aging
Enrollment
30
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · OTHER · TRIPLE
Evidence population
Human clinical study registration
Participants
30
Population
FEMALE · 45 Years to 65 Years
Duration
2025-04-01 to 2026-06-30
Intervention
GLYLO; Placebo
Comparator
Placebo
Outcomes measured
Methylglyoxal (MGO) — Baseline, Week 12, Week 24; Advance glycation end products (AGE) — Baseline, Week 12, Week 24; Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) — Baseline, Week 12, Week 24; HbA1c — Baseline, Week 12, Week 24; Body fat — Baseline, Week 12, Week 24; Body mass index (BMI) — Baseline, Week 12, Week 24; Hip circumference — Baseline, Week 12, Week 24; Follicle-stimulating hormone (FSH) — Baseline, Week 12, Week 24; Muscle mass — Baseline, Week 12, Week 24; Waist circumference — Baseline, Week 12, Week 24
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Glycation and AGEs · 100%Title contains controlled term: glycation. Abstract contains controlled term: advanced glycation end product, glycation. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

glycation ages
Open primary sourceExport JSON